Constance, Germany

Uwe Kruger

This inventor holds 2 USPTO granted patents. Top assignee: Byk Gulden Lomberg Chemische Fabrik Gmbh. Active years: 1982-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uwe Kruger. Retrieved from https://idiyas.com/inventor/uwe-kruger-nz1aaks9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1982-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Uwe Kruger: Innovator in Medicinal Chemistry

Introduction

Uwe Kruger is a notable inventor based in Constance, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work has the potential to impact the medical community positively.

Latest Patents

Uwe Kruger's latest patents include innovative formulations such as "Mental complexes having an antineoplastic action" and "Medicaments - .omega.-[2-(N-Lower alkyl-benzamido)-phenyl]-alkanoic acids, their use." These inventions focus on the preparation and application of specific chemical compounds that may offer new avenues for treatment in various medical conditions.

Career Highlights

Throughout his career, Uwe has been associated with Byk Gulden Lomberg Chemische Fabrik GmbH, where he has contributed to research and development efforts. His expertise in medicinal chemistry has allowed him to explore and create effective medicinal compounds.

Collaborations

Uwe has worked alongside esteemed colleagues such as Bernhard Keppler and Kurt Klemm. Their collaborative efforts have further advanced the research and development of innovative medicinal solutions.

Conclusion

Uwe Kruger stands out as a dedicated inventor in the field of medicinal chemistry, with a focus on developing compounds that could lead to significant medical advancements. His contributions through patents and collaborations highlight his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…